NCT04102761View on ClinicalTrials.gov

The Use of PRP and BMC in Patients With Internal Disc Disruption Multicenter Prospective Randomized Controlled Trial in Patients With Internal Disc Disruption

NACompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

March 27, 2018

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Internal Disc Disruption
Interventions
PROCEDURE

Intradiscal PRP & BMC Injections

The intervention to be studied is the intradiscal delivery of autologous Platelet Rich Plasma (PRP) or bone marrow concentrate (BMC) into the nucleus pulposus of the disrupted disc(s).

Trial Locations (4)

75701

Texas Spine and Joint Hospital, Tyler

84604

Nexus Pain Care, Provo

90025

The Orthohealing Center, Los Angeles

95008

Alex Hames, Campbell

All Listed Sponsors
collaborator

Andrews Research & Education Foundation

OTHER

lead

Annu Navani

OTHER

NCT04102761 - The Use of PRP and BMC in Patients With Internal Disc Disruption Multicenter Prospective Randomized Controlled Trial in Patients With Internal Disc Disruption | Biotech Hunter | Biotech Hunter